MarketCap
Xenon Pharmaceuticals XENE
€ 33.56
4.68%
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
79.3 M |
Marktkapitalisierung |
$ 2.98 B |
EBITDA (LTM) |
$ -371 M |
P/E (LTM) |
-13.704128 |
P/S (LTM) |
631.388216 |
EPS (LTM) |
-4.36 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals
REGN
|
$ 726.47 | 0.05 % | $ 76 B | Nasdaq Global Select Market,SPB |  USA |
 |
Replimune Group
REPL
|
$ 13.15 | 0.61 % | $ 1.22 B | Nasdaq Global Select Market | USA |
 |
Rafael Holdings
RFL
|
$ 1.47 | 0.65 % | $ 43.3 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.76 | 4.44 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 47.79 | 1.36 % | $ 860 M | Nasdaq Global Select Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 19.39 | 2.27 % | $ 3.33 B | Nasdaq Global Market | USA |
 |
Avidity Biosciences
RNA
|
$ 7.97 | 1.66 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 56.66 | 0.36 % | $ 24.4 B | Nasdaq Global Select Market | USA |
 |
Revolution Medicines
RVMD
|
$ 207.68 | 0.5 % | $ 39.5 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 92.45 | 0.24 % | $ 6.01 B | Nasdaq Global Market,SPB | USA |
 |
Rezolute
RZLT
|
$ 4.33 | 7.98 % | $ 450 M | Nasdaq Capital Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.88 | 1.21 % | $ 729 M | Nasdaq Global Select Market | USA |
 |
Seer
SEER
|
$ 2.33 | 3.56 % | $ 129 M | Nasdaq Global Select Market | USA |
 |
SIGA Technologies
SIGA
|
$ 3.48 | 2.96 % | $ 249 M | Nasdaq Global Select Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 78.95 | 9.65 % | $ 220 M | Nasdaq Global Select Market |  Israel |
|
Silence Therapeutics plc
SLN
|
$ 10.14 | 0.78 % | $ 1.44 B | Nasdaq Global Select Market |  Britain |
 |
SELLAS Life Sciences Group
SLS
|
$ 11.63 | 3.62 % | $ 1.27 B | Nasdaq Capital Market | USA |
 |
Summit Therapeutics
SMMT
|
$ 17.27 | 3.07 % | $ 12.9 B | Nasdaq Global Select Market | Britain |
 |
Syndax Pharmaceuticals
SNDX
|
$ 17.83 | 1.31 % | $ 1.54 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.36 | 0.6 % | $ 1.87 M | Nasdaq Capital Market | USA |
 |
Sanofi
SNY
|
$ 39.51 | 1.19 % | $ 48.2 B | Nasdaq Global Select Market |  France |
 |
Spruce Biosciences
SPRB
|
$ 45.42 | 2.1 % | $ 34.8 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.16 | 4.13 % | $ 65 M | Nasdaq Global Select Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 17.49 | 0.7 % | $ 1.75 B | Nasdaq Global Select Market,SPB | USA |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 43.4 | 1.41 % | $ 4.98 B | Nasdaq Global Select Market | USA |
 |
Stoke Therapeutics
STOK
|
$ 25.32 | 0.8 % | $ 1.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 15.13 | 0.23 % | $ 129 M | Nasdaq Global Select Market | USA |
 |
Shattuck Labs
STTK
|
$ 6.5 | 1.04 % | $ 452 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 42.76 | 0.9 % | $ 2.41 B | Nasdaq Global Select Market,SPB | USA |
 |
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market | USA |
 |
Savara
SVRA
|
$ 4.78 | 0.1 % | $ 1.06 B | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 2.08 | 1.99 % | $ 1.41 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 17.81 | 0.08 % | $ 28.1 B | NYSE |  Japan |
|
Protara Therapeutics
TARA
|
$ 2.63 | 0.36 % | $ 113 M | Nasdaq Global Market | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 74.46 | 1.99 % | $ 3.11 B | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.58 | 0.25 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Tenax Therapeutics
TENX
|
$ 1.96 | 2.59 % | $ 76.9 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 39.66 | 0.33 % | $ 45.4 B | NYSE | Israel |
 |
TG Therapeutics
TGTX
|
$ 53.91 | 0.12 % | $ 7.78 B | Nasdaq Capital Market | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 8.07 | 0.54 % | $ 68.7 M | Nasdaq Global Select Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 13.72 | 0.99 % | $ 1.85 B | Nasdaq Global Market | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.49 | 0.11 % | $ 1.44 B | Nasdaq Global Select Market | USA |
 |
UroGen Pharma Ltd.
URGN
|
$ 42.78 | 3.33 % | $ 2.06 B | Nasdaq Global Select Market | Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 536.4 | 0.37 % | $ 23.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Vericel Corporation
VCEL
|
$ 41.07 | 2.29 % | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 47.67 | 4.06 % | $ 3.75 B | Nasdaq Global Market,SPB | USA |
 |
Vir Biotechnology
VIR
|
$ 11.78 | 5.46 % | $ 1.63 B | Nasdaq Global Select Market,SPB | USA |
 |
Viking Therapeutics
VKTX
|
$ 29.28 | 0.36 % | $ 3.3 B | Nasdaq Capital Market | USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 4.58 | 0.51 % | $ 270 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 4.31 | 0.21 % | $ 45.9 M | Nasdaq Global Market | USA |